Dutch Technology Foundation STW
9
344K
8
0.23
6
0.11
- Areas of investment
Summary
Dutch Technology Foundation STW appeared to be the Corporate Investor, which was created in 1981. The leading representative office of defined Corporate Investor is situated in the Utrecht. The company was established in Europe in The Netherlands.
The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year. Speaking about the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. Deals in the range of 100 thousands - 1 million dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 1-2 partakers. The meaningful sponsors for the fund in investment in the same round are RedMedtech Ventures, LLX2 Investments, Horizon 2020. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Horizon 2020, High Tech Fund.
Among the most popular fund investment industries, there are Therapeutics, Biopharma. Among the most popular portfolio startups of the fund, we may highlight LipoCoat. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup needs to be aged 1 and less years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 6
- Rounds per year
- 0.23
- Follow on index
- 0.11
- Investments by industry
- Biotechnology (4)
- Medical Device (3)
- Medical (3)
- Information Services (3)
- Life Science (2) Show 17 more
- Investments by region
-
- Netherlands (9)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.11
Data1 Finished!
Buy stuff!
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| LipoCoat | 13 Jul 2017 | Biotechnology, Health Care, Medical Device, Medical | Seed | 1M | Overijssel, Enschede, Netherlands |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.